Primary Ovarian Malignant Melanoma: A Case Report

Primary ovarian melanoma (POM) is an exceedingly rare and aggressive form of melanoma that arises in the ovaries, distinct from metastatic ovarian melanoma, which is far more common. The rarity of this condition, coupled with its clinical similarities to other types of ovarian malignancies, makes it a challenging entity to diagnose and manage. We present the case of a 56-year-old woman who underwent a laparoscopically assisted vaginal hysterectomy and bilateral salpingo-oophorectomy due to pelvic organ prolapse and a left adnexal mass. The final histology showed a POM. She received adjuvant immunotherapy, and a year after the initial diagnosis, the patient remains alive and well, without any signs of recurrence or distant disease.

Authors

Institutions

Publication Details

Journal
Cureus
Published
2025-05-16
DOI
https://doi.org/10.7759/cureus.84249
Primary Topic
Cutaneous Melanoma Detection and Management
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Primary Ovarian Malignant Melanoma: A Case Report

Despoina Myoteri, Porfyrios Korompelis, Theodoros Panoskaltsis, Panagiotis Vakas et al.
Cureus
Cutaneous Melanoma Detection and Management
article

Primary Ovarian Malignant Melanoma: A Case Report

Despoina Myoteri, Porfyrios Korompelis, Theodoros Panoskaltsis, Panagiotis Vakas, Maria Zoi Bourou
article en

Abstract

Primary ovarian melanoma (POM) is an exceedingly rare and aggressive form of melanoma that arises in the ovaries, distinct from metastatic ovarian melanoma, which is far more common. The rarity of this condition, coupled with its clinical similarities to other types of ovarian malignancies, makes it a challenging entity to diagnose and manage. We present the case of a 56-year-old woman who underwent a laparoscopically assisted vaginal hysterectomy and bilateral salpingo-oophorectomy due to pelvic organ prolapse and a left adnexal mass. The final histology showed a POM. She received adjuvant immunotherapy, and a year after the initial diagnosis, the patient remains alive and well, without any signs of recurrence or distant disease.

CureusVol. 17(5)
National and Kapodistrian University of Athens (GR), Queen Elizabeth Hospital (GB)
Zero hunger
Openalex Percentile: Top 84%
Cutaneous Melanoma Detection and Management
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.